CT.gov Narrative Gap Repeaters
2026-03-29 | full-registry ct.gov audit | plots, figures, and e156 bundle
Series
IndustrySponsor-ClassPhaseStructural MissingnessEvidence VisibilityCompletion CohortCondition HiddennessSponsor ConcentrationRule-Era ReportingPublication UndercountOncology HiddennessCardiovascular HiddennessMetabolic HiddennessEnrollment-SizeGeography-ScaleDesign-PurposeCompletion-DelayTrial-ArchitectureIntervention-TypeCountry ReportingStopped-TrialOutcome-DensityActual-FieldUs-Versus-GlobalModality-SponsorCountry-ConditionDisease-GeographyCondition-SponsorCountry-SponsorUs-Versus-Ex-UsIndustry-FamilyRisk-Adjusted HiddennessOverdue Results ClockPublication Index GapProbable Act/Fdaaa DebtSponsor Excess WatchlistCountry Excess WatchlistCondition Excess WatchlistBlack-Box TrialsStrict-Proxy RepeatersSponsor Ghost RepeatersCountry Ghost WatchlistCondition Ghost WatchlistBlack-Box Sponsor RepeatersStrict-Core Black-BoxSponsor DebtCountry DebtCondition DebtNarrative GapsActual Discipline
Narrative Gaps Dashboard

Narrative-gap repeaters show where CT.gov pages remain text-thin even when other registry fields are present

Boehringer Ingelheim leads narrative-gap stock, Roche and GlaxoSmithKline remain close behind, Mylan is the sharpest large-sponsor rate outlier, and healthy-volunteer studies are the clearest condition-family narrative-gap extreme.

Open dashboardRead E156 paperProtocolSeries hub
Stock
Rates
Conditions
Narrative

Dashboard

Open dashboard at rootRead E156 micro-paperOpen protocolOpen series hub

Boehringer Ingelheim leads the narrative-gap stock table, Roche and GlaxoSmithKline remain close behind, Mylan is the sharpest rate outlier, and healthy volunteers are the clearest condition-family extreme.

How to read the dashboard
Boehringer gap
706
Narrative-gap stock
Roche gap
555
Narrative-gap stock
Mylan rate
93.7%
Large-sponsor rate
Healthy rate
22.0%
Condition rate
Top sponsor narrative-gap stock
NARRATIVE-GAP STOCKTop sponsor counts missing both detailed and primary-outcome descriptionsBoehringer706Hoffmann-La Roche555GlaxoSmithKline526Pfizer519AstraZeneca501Novo Nordisk A/S459Novartis Pharmaceuticals454Sanofi450Bayer417BMS396
Boehringer Ingelheim, Roche, GlaxoSmithKline, Pfizer, and AstraZeneca dominate the narrative-gap stock table.
Textual opacity is concentrated in a short sponsor list.
Large-sponsor narrative-gap rate
NARRATIVE-GAP RATENarrative-gap rate among named sponsors with at least 100 older studiesMylan Pharmaceuticals Inc93.7%Centre Hospitalier Universitaire Dijon68.9%Novartis60.1%Sandoz58.6%Institute of Liver and Biliary Sciences, India55.3%Novo Nordisk A/S54.4%Wyeth is now a wholly owned subsidiary of Pfizer54.1%Genentech, Inc.48.9%Tanabe Pharma Corporation47.1%Kyowa Kirin Co., Ltd.46.8%
Mylan Pharmaceuticals Inc is the sharpest large-sponsor rate outlier, with several other industry portfolios also extremely text-thin.
Stock and rate identify overlapping but not identical repeaters.
Condition-family narrative-gap rate
CONDITION NARRATIVE-GAP RATENarrative-gap rate across condition familiesHealthy volunteers22.0%Metabolic14.8%Renal and urology14.6%Cardiovascular12.4%Gastrointestinal and hepatic12.3%Respiratory and sleep11.9%Immunology and dermatology11.6%Infectious disease10.1%Reproductive and maternal10.0%Oncology9.7%
Healthy volunteers are the clearest condition-family extreme, well above the major named disease families.
That makes narrative gaps a different therapeutic pattern than ordinary missing-results stock.
Read Across Projects

Across The Series

Each project isolates a different dimension of registry opacity, but the point is the contrast between them, not a single leaderboard.

Industry
Industry project

Industry project from the CT.gov hiddenness series.

Sponsor-Class
Sponsor-class project

Sponsor-class project from the CT.gov hiddenness series.

Phase
Phase project

Phase project from the CT.gov hiddenness series.

Structural Missingness
Structural missingness project

Structural missingness project from the CT.gov hiddenness series.

Evidence Visibility
Evidence visibility project

Evidence visibility project from the CT.gov hiddenness series.

Completion Cohort
Completion cohort project

Completion cohort project from the CT.gov hiddenness series.

Condition Hiddenness
Condition hiddenness project

Condition hiddenness project from the CT.gov hiddenness series.

Sponsor Concentration
Sponsor concentration project

Sponsor concentration project from the CT.gov hiddenness series.

Rule-Era Reporting
Rule-era reporting project

Rule-era reporting project from the CT.gov hiddenness series.

Publication Undercount
Publication undercount audit

Publication undercount audit from the CT.gov hiddenness series.

Oncology Hiddenness
Oncology hiddenness project

Oncology hiddenness project from the CT.gov hiddenness series.

Cardiovascular Hiddenness
Cardiovascular hiddenness project

Cardiovascular hiddenness project from the CT.gov hiddenness series.

Metabolic Hiddenness
Metabolic hiddenness project

Metabolic hiddenness project from the CT.gov hiddenness series.

Enrollment-Size
Enrollment-size project

Enrollment-size project from the CT.gov hiddenness series.

Geography-Scale
Geography-scale project

Geography-scale project from the CT.gov hiddenness series.

Design-Purpose
Design-purpose project

Design-purpose project from the CT.gov hiddenness series.

Completion-Delay
Completion-delay project

Completion-delay project from the CT.gov hiddenness series.

Trial-Architecture
Trial-architecture project

Trial-architecture project from the CT.gov hiddenness series.

Intervention-Type
Intervention-type project

Intervention-type project from the CT.gov hiddenness series.

Country Reporting
Country reporting project

Country reporting project from the CT.gov hiddenness series.

Stopped-Trial
Stopped-trial project

Stopped-trial project from the CT.gov hiddenness series.

Outcome-Density
Outcome-density project

Outcome-density project from the CT.gov hiddenness series.

Actual-Field
Actual-field project

Actual-field project from the CT.gov hiddenness series.

Us-Versus-Global
US-versus-global project

US-versus-global project from the CT.gov hiddenness series.

Modality-Sponsor
Modality-sponsor project

Modality-sponsor project from the CT.gov hiddenness series.

Country-Condition
Country-condition project

Country-condition project from the CT.gov hiddenness series.

Disease-Geography
Disease-geography project

Disease-geography project from the CT.gov hiddenness series.

Condition-Sponsor
Condition-sponsor project

Condition-sponsor project from the CT.gov hiddenness series.

Country-Sponsor
Country-sponsor project

Country-sponsor project from the CT.gov hiddenness series.

Us-Versus-Ex-Us
US-versus-ex-US project

US-versus-ex-US project from the CT.gov hiddenness series.

Industry-Family
Industry-family project

Industry-family project from the CT.gov hiddenness series.

Risk-Adjusted Hiddenness
Risk-adjusted hiddenness

Risk-adjusted hiddenness from the CT.gov hiddenness series.

Overdue Results Clock
Overdue results clock

Overdue results clock from the CT.gov hiddenness series.

Publication Index Gap
Publication index gap

Publication index gap from the CT.gov hiddenness series.

Probable Act/Fdaaa Debt
Probable ACT/FDAAA debt

Probable ACT/FDAAA debt from the CT.gov hiddenness series.

Sponsor Excess Watchlist
Sponsor excess watchlist

Sponsor excess watchlist from the CT.gov hiddenness series.

Country Excess Watchlist
Country excess watchlist

Country excess watchlist from the CT.gov hiddenness series.

Condition Excess Watchlist
Condition excess watchlist

Condition excess watchlist from the CT.gov hiddenness series.

Black-Box Trials
Black-box trials

Black-box trials from the CT.gov hiddenness series.

Strict-Proxy Repeaters
Strict-proxy repeaters

Strict-proxy repeaters from the CT.gov hiddenness series.

Sponsor Ghost Repeaters
Sponsor ghost repeaters

Sponsor ghost repeaters from the CT.gov hiddenness series.

Country Ghost Watchlist
Country ghost watchlist

Country ghost watchlist from the CT.gov hiddenness series.

Condition Ghost Watchlist
Condition ghost watchlist

Condition ghost watchlist from the CT.gov hiddenness series.

Black-Box Sponsor Repeaters
Black-box sponsor repeaters

Black-box sponsor repeaters from the CT.gov hiddenness series.

Strict-Core Black-Box
Strict-core black-box

Strict-core black-box from the CT.gov hiddenness series.

Sponsor Debt
CT.gov Sponsor Overdue Debt

Named-sponsor overdue-debt tables showing which portfolios hold the largest unresolved years beyond the two-year mark.

Country Debt
CT.gov Country Overdue Debt

Country-linked overdue-debt tables showing where unresolved years beyond the two-year mark accumulate most heavily.

Condition Debt
CT.gov Condition Overdue Debt

Condition-family overdue-debt tables showing which therapeutic portfolios hold the deepest unresolved reporting years.

Actual Discipline
CT.gov Actual-Discipline Repeaters

Named-sponsor actual-field tables showing where actual completion and actual enrollment discipline remains weak.

Source on GitHub | Project home | Dashboard